Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05465382Terminated
Randomised, open-label trial (2 arms), sponsored by Duke University. Primary endpoints: Change in Cytokine Levels, Change in CTX-II (C-telopeptide of Type II Collagen) Level and 1 more. Started Jul 2022; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05465382.